Microinjection	microinjection	O	O
of	of	O	O
ritanserin	ritanserin	S_chemicals	O
into	into	O	O
the	the	O	O
CA1	ca1	O	S_disease
region	region	O	O
of	of	O	O
hippocampus	hippocampus	O	O
improves	improves	O	O
scopolamine-induced	scopolamine-induced	O	O
amnesia	amnesia	O	S_disease
in	in	O	O
adult	adult	O	O
male	male	O	O
rats	rats	O	O
.	.	O	O

The	the	O	O
effect	effect	O	O
of	of	O	O
ritanserin	ritanserin	S_chemicals	O
(	(	O	O
5-HT2	5-ht2	O	O
antagonist	antagonist	O	O
)	)	O	O
on	on	O	O
scopolamine	scopolamine	S_chemicals	O
(	(	O	O
muscarinic	muscarinic	B_chemicals	O
cholinergic	cholinergic	S_chemicals	O
antagonist)-induced	antagonist)-induced	O	O
amnesia	amnesia	O	S_disease
in	in	O	O
Morris	morris	O	O
water	water	S_chemicals	O
maze	maze	O	O
(	(	O	O
MWM	mwm	O	O
)	)	O	O
was	was	O	O
investigated	investigated	O	O
.	.	O	O

Rats	rats	O	O
were	were	O	O
divided	divided	O	O
into	into	O	O
eight	eight	O	O
groups	groups	O	O
and	and	O	O
bilaterally	bilaterally	O	O
cannulated	cannulated	O	O
into	into	O	O
CA1	ca1	O	S_disease
region	region	O	O
of	of	O	O
the	the	O	O
hippocampus	hippocampus	O	O
.	.	O	O

One	one	O	O
week	week	O	O
later	later	O	O
,	,	O	O
they	they	O	O
received	received	O	O
repeatedly	repeatedly	O	O
vehicles	vehicles	O	O
(	(	O	O
saline	saline	O	O
,	,	O	O
DMSO	dmso	S_chemicals	O
,	,	O	O
saline+DMSO	saline+dmso	O	O
)	)	O	O
,	,	O	O
scopolamine	scopolamine	S_chemicals	O
(	(	B_chemicals	O
2	2	I_chemicals	O
microg/0.5	microg/0.5	O	O
microl	microl	O	O
saline/side	saline/side	O	O
;	;	O	O
30	30	O	O
min	min	O	O
before	before	O	O
training	training	O	O
)	)	O	O
,	,	O	O
ritanserin	ritanserin	S_chemicals	O
(	(	B_chemicals	O
2	2	I_chemicals	O
,	,	O	O
4	4	O	O
and	and	O	O
8	8	O	O
microg/0.5	microg/0.5	O	O
microl	microl	O	O
DMSO/side	dmso/side	O	O
;	;	O	O
20	20	O	O
min	min	O	O
before	before	O	O
training	training	O	O
)	)	O	O
and	and	O	O
scopolamine	scopolamine	S_chemicals	O
(	(	B_chemicals	O
2	2	I_chemicals	O
microg/0.5	microg/0.5	O	O
microl	microl	O	O
;	;	O	O
30	30	O	O
min	min	O	O
before	before	O	O
ritanserin	ritanserin	S_chemicals	O
injection)+ritanserin	injection)+ritanserin	O	O
(	(	O	O
4	4	O	O
microg/0.5	microg/0.5	O	O
microl	microl	O	O
DMSO	dmso	S_chemicals	O
)	)	O	O
through	through	O	O
cannulae	cannulae	O	O
each	each	O	O
day	day	O	O
.	.	O	O

Animals	animals	O	O
were	were	O	O
tested	tested	O	O
for	for	O	O
four	four	O	O
consecutive	consecutive	O	O
days	days	O	O
(	(	O	O
4	4	O	O
trial/day	trial/day	O	O
)	)	O	O
in	in	O	O
MWM	mwm	O	O
during	during	O	O
which	which	O	O
the	the	O	O
position	position	O	O
of	of	O	O
hidden	hidden	O	O
platform	platform	O	O
was	was	O	O
unchanged	unchanged	O	O
.	.	O	O

In	in	O	O
the	the	O	O
fifth	fifth	O	O
day	day	O	O
,	,	O	O
the	the	O	O
platform	platform	O	O
was	was	O	O
elevated	elevated	O	O
above	above	O	O
the	the	O	O
water	water	S_chemicals	O
surface	surface	O	O
in	in	O	O
another	another	O	O
position	position	O	O
to	to	O	O
evaluate	evaluate	O	O
the	the	O	O
function	function	O	O
of	of	O	O
motor	motor	O	O
,	,	O	O
motivational	motivational	O	O
and	and	O	O
visual	visual	O	O
systems	systems	O	O
.	.	O	O

The	the	O	O
results	results	O	O
showed	showed	O	O
a	a	O	O
significant	significant	O	O
increase	increase	O	O
in	in	O	O
escape	escape	O	O
latencies	latencies	O	O
and	and	O	O
traveled	traveled	O	O
distances	distances	O	O
to	to	O	O
find	find	O	O
platform	platform	O	O
in	in	O	O
scopolamine-treated	scopolamine-treated	O	O
group	group	O	O
as	as	O	O
compared	compared	O	O
to	to	O	O
saline	saline	O	O
group	group	O	O
.	.	O	O

Ritanserin-treated	ritanserin-treated	O	O
rats	rats	O	O
(	(	O	O
4	4	O	O
microg/0.5	microg/0.5	O	O
microl/side	microl/side	O	O
)	)	O	O
showed	showed	O	O
a	a	O	O
significant	significant	O	O
decrease	decrease	O	O
in	in	O	O
the	the	O	O
mentioned	mentioned	O	O
parameters	parameters	O	O
as	as	O	O
compared	compared	O	O
to	to	O	O
DMSO-treated	dmso-treated	O	O
group	group	O	O
.	.	O	O

However	however	O	O
,	,	O	O
scopolamine	scopolamine	S_chemicals	O
and	and	O	O
ritanserin	ritanserin	S_chemicals	O
co-administration	co-administration	O	O
resulted	resulted	O	O
in	in	O	O
a	a	O	O
significant	significant	O	O
decrease	decrease	O	O
in	in	O	O
escape	escape	O	O
latencies	latencies	O	O
and	and	O	O
traveled	traveled	O	O
distances	distances	O	O
as	as	O	O
compared	compared	O	O
to	to	O	O
the	the	O	O
scopolamine-treated	scopolamine-treated	O	O
rats	rats	O	O
.	.	O	O

Our	our	O	O
findings	findings	O	O
show	show	O	O
that	that	O	O
microinjection	microinjection	O	O
of	of	O	O
ritanserin	ritanserin	S_chemicals	O
into	into	O	O
the	the	O	O
CA1	ca1	O	S_disease
region	region	O	O
of	of	O	O
the	the	O	O
hippocampus	hippocampus	O	O
improves	improves	O	O
the	the	O	O
scopolamine-induced	scopolamine-induced	O	O
amnesia	amnesia	O	S_disease
.	.	O	O

